LYEL earnings: a positive outcome, +7.6%

On May 6, 2024, Lyell Immunopharma, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.6% in the window around the event. It had already run +12.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.